10.55
+0.19%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Joincare Pharmaceutical Group Industry Co
Its shares trade on Shanghai under the ticker 600380.SS. It has been listed since 8 June 2001. In the fiscal year to 31 December 2025, it reported revenue of CN¥15.22bn and net income of CN¥1.34bn. At that date it held total assets of CN¥35.41bn and shareholders' equity of CN¥15.18bn.
Joincare Pharmaceutical Group Industry Co., Ltd. principally engages in the research, development, production, and sale of pharmaceutical products and healthcare products. The company is headquartered in Shenzhen, Guangdong. The company went IPO on 2001-06-08. The firm's products include chemical materials and intermediates, chemical agents, health products, traditional Chinese medicines, diagnostic reagents and equipment. The firm is also engaged in electricity business. The firm distributes its products within domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 8 Jun 2001
- Employees
- 14,116
- Website
- joincare.com ↗
Leadership
Pay as last reported
- Mr. Baoguo ZhuChairman of the Board, since 1992CN¥3.3m
- Mr. Nanqi LinPresident, Director, since 2021CN¥2.3m
- Ms. Guangxia LiuVice Chairman of the BoardCN¥4.4m
- Mr. Qingfeng QiuFinance Director, Vice President, DirectorCN¥2.3m
- Mr. Zhiwei XingVice President, Director, since 2024
- Ms. Yanmei DuVice President
- Mr. Tingke TangVice President
- Mr. Leiming ZhangVice PresidentCN¥2.0m
- Mr. Yifan ZhuSecretary of the Board
- Ms. Jing HuoIndependent DirectorCN¥120,000
- Ms. Juan PengIndependent DirectorCN¥120,000
- Mr. Yezhi QinIndependent DirectorCN¥120,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 92
- Environment
- 99
- Social
- 99
- Governance
- 79
- Direct emissions (scope 1)
- 197,854.4 t
- Energy emissions (scope 2)
- 828,817.7 t
- Women in the workforce
- 46.21603%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Joincare Pharmaceutical Group Industry Co Ltd employs 14,116 full-time employees in Shenzhen, CN.
- The company produces chemical materials, intermediates, and traditional Chinese medicines for domestic and overseas markets.
- Joincare's diverse product portfolio includes diagnostic reagents, equipment, and health products.
Weaknesses
- Joincare's electricity business is a minor segment within its overall operations.
- The company's focus on domestic market distribution limits international expansion opportunities.
- Shenzhen headquarters location may not provide strategic advantages for global operations.
Opportunities
- Growing demand for traditional Chinese medicines in global healthcare markets presents opportunities.
- Expanding diagnostic reagents and equipment sales to overseas markets can increase revenue streams.
- Increasing health product demand within China's domestic market offers growth potential.
Threats
- Competition from other pharmaceutical companies in the CN market poses a threat.
- Regulatory changes in the Chinese healthcare sector could impact operations.
- Overreliance on domestic market distribution may expose the company to economic fluctuations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.